Skip to content
Home
Julietta Fiscella, M.D.

Julietta Fiscella, M.D.

Contact

Office (585) 341-8075
Fax (585) 341-8267
Administrative (585) 341-6801

About Me

Dr. Fiscella is Director of Pathology, Highland Hospital Laboratories. Her clinical subspecialty interests include gyn pathology, cytopathology, pulmonary pathology, and quality assurance.
Dr. Fiscella is Director of Pathology, Highland Hospital Laboratories. Her clinical subspecialty interests include gyn pathology, cytopathology, pulmonary pathology, and quality assurance.

Faculty Appointments

Chief, Pathology, Highland Hosp Labs - Department of Pathology and Laboratory Medicine (SMD)

Credentials

Post-doctoral Training & Residency

Resident in Pathology, University of Rochester, Strong Memorial Hospital 1992 - 1995

Resident in Pathology, SUNY Buffalo, Buffalo General Hospital 1990 - 1992

Education

MD | University at Buffalo SUNY School of Medicine & Biomedical Sciences. Medicine. 1988

Bachelor of Science | St. John's University. Biology. 1983

Research

Dr. Fiscella's research interests have included the effects of gamma interferon on pulmonary interstitial fibrosis, and the effects of mifepristone on intrauterine leiomyomas.
Dr. Fiscella's research interests have included the effects of gamma interferon on pulmonary interstitial fibrosis, and the effects of mifepristone on intrauterine leiomyomas.

Publications

Journal Articles

Introducing Patients to Their Pathology Reports

Fiscella, J.

CAP Today. 2014; 28(1): 54 - 55.

Fiscella, J.; Ahmed, B.

Pathologists Can Explain Surgical Pathology to Patients:

Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone.

Fiscella J, Bonfiglio T, Winters P, Eisinger SH, Fiscella K

Human pathology.. 2011 July 42 (7):947-53. Epub 02/11/2011.

Distinguishing Features of Endometrial Pathology After Exposure to the Progesterone Receptor Modulator Mifepristone.

Fiscella, J.; Bonfiglio, T.; Winters, P.; Eisenger, S.H.; Fiscella, K.

Human Pathology. 2011; 42(7): 947-953.

Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.

Eisinger SH, Fiscella J, Bonfiglio T, Meldrum S, Fiscella K

European journal of obstetrics, gynecology, and reproductive biology.. 2009 October 146 (2):215-8. Epub 07/07/2009.

Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata

Eisinger, S.H.; Fiscella, J.; Bonfiglio, T.; Meldrum, S.; Fiscella, K.

European Journal of Obstetrics & Gynecology and Reproductive Biology. 2009; 146: 215-218.

Eccrine porocarcinoma.

Goedde TA, Bumpers H, Fiscella J, Rao U, Karakousis CP

Journal of surgical oncology.. 1994 April 55 (4):261-4. Epub 1900 01 01.